Avila-Moreno F, Armas-Lopez L, Alvarez-Moran AM, et al. 2014 Overexpression of MEOX2 and TWIST1 is associated with H3K27me3 levels and determines lung cancer chemoresistance and prognosis. PLoS One 9 e114104

Article  Google Scholar 

Bernard BJ, Nigam N, Burkitt K and Saloura V 2021 SMYD3: a regulator of epigenetic and signaling pathways in cancer. Clin. Epigenet. 13 45

CAS  Article  Google Scholar 

Chen Z, Fillmore CM, Hammerman PS, Kim CF and Wong KK 2014 Non-small-cell lung cancers: a heterogeneous set of diseases. Nat. Rev. Cancer 14 535–546

CAS  Article  Google Scholar 

Chen D, Meng W, Shu L, et al. 2020 ANO1 in urethral SMCs contributes to sex differences in urethral spontaneous tone. Am. J. Physiol. Renal Physiol. 319 F394–F402

CAS  Article  Google Scholar 

Cock-Rada AM, Medjkane S, Janski N, et al. 2012 SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9. Cancer Res. 72 810–820

CAS  Article  Google Scholar 

Dulin NO 2020 Calcium-activated chloride channel ANO1/TMEM16A: Regulation of expression and signaling. Front. Physiol. 11 590262

Article  Google Scholar 

Fenizia C, Bottino C, Corbetta S, et al. 2019 SMYD3 promotes the epithelial-mesenchymal transition in breast cancer. Nucleic Acids Res. 47 1278–1293

CAS  Article  Google Scholar 

Giakountis A, Moulos P, Sarris ME, Hatzis P and Talianidis I 2017 Smyd3-associated regulatory pathways in cancer. Semin. Cancer Biol. 42 70–80

CAS  Article  Google Scholar 

Guan L, Song Y, Gao J, Gao J and Wang K 2016 Inhibition of calcium-activated chloride channel ANO1 suppresses proliferation and induces apoptosis of epithelium originated cancer cells. Oncotarget 7 78619–78630

Article  Google Scholar 

Guo S, Chen Y, Shi S, et al. 2020 Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy. Pharmacol. Res. 155 104721

CAS  Article  Google Scholar 

He Y, Li H, Chen Y, et al. 2017 Expression of anoctamin 1 is associated with advanced tumor stage in patients with non-small cell lung cancer and predicts recurrence after surgery. Clin. Transl. Oncol. 19 1091–1098

CAS  Article  Google Scholar 

Herbst RS, Morgensztern D and Boshoff C 2018 The biology and management of non-small cell lung cancer. Nature 553 446–454

CAS  Article  Google Scholar 

Hirsch FR, Scagliotti GV, Mulshine JL, et al. 2017 Lung cancer: current therapies and new targeted treatments. Lancet 389 299–311

CAS  Article  Google Scholar 

Hou Z, Sun L, Xu F, et al. 2020 Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer. Cancer Lett. 487 63–73

CAS  Article  Google Scholar 

Hu C, Zhang R and Jiang D 2019 TMEM16A as a potential biomarker in the diagnosis and prognosis of lung cancer. Arch. Iran. Med. 22 32–38

PubMed  Google Scholar 

Jiang Y, Lyu T, Che X, Jia N, Li Q and Feng W 2019 Overexpression of SMYD3 in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via methylating H3K4 and H4K20. J. Cancer 8 4072–4084

Article  Google Scholar 

Kim D, Kim Y, Lee BB, et al. 2021 Metformin reduces histone H3K4me3 at the promoter regions of positive cell cycle regulatory genes in lung cancer cells. Cancers 13 739

CAS  Article  Google Scholar 

Leng X, Wang J, An N, et al. 2020 Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3. Oncogene 39 6468–6479

CAS  Article  Google Scholar 

Li J, Zhao L, Pan Y, et al. 2020 SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in nonsmall cell lung cancer. Int. J. Oncol. 57 756–766

CAS  Article  Google Scholar 

Liu Z, Zhang S, Hou F, et al. 2019 Inhibition of Ca(2+)-activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K/Akt signaling. Int. J. Cancer 144 2215–2226

CAS  Article  Google Scholar 

Lv HW, Xing WQ, Ba YF, et al. 2021 SMYD3 confers cisplatin chemoresistance of NSCLC cells in an ANKHD1-dependent manner. Transl. Oncol. 14 101075

Article  Google Scholar 

Lyu T, Jiang Y, Jia N, et al. 2020 SMYD3 promotes implant metastasis of ovarian cancer via H3K4 trimethylation of integrin promoters. Int. J. Cancer 146 1553–1567

CAS  Article  Google Scholar 

Mayr C, Helm K, Jakab M, et al. 2018 The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer. Hum. Pathol. 72 117–126

CAS  Article  Google Scholar 

Mazzone A, Eisenman ST, Strege PR, et al. 2012 Inhibition of cell proliferation by a selective inhibitor of the Ca(2+)-activated Cl(−) channel, Ano1. Biochem. Biophys. Res. Commun. 427 248–253

CAS  Article  Google Scholar 

Seo Y, Jeong SB, Woo JH, et al. 2021 Diethylstilbestrol, a novel ANO1 inhibitor, exerts an anticancer effect on non-small cell lung cancer via inhibition of ANO1. Int. J. Mol. Sci. 22 7100

CAS  Article  Google Scholar 

Shang L and Wei M 2019 Inhibition of SMYD2 sensitized cisplatin to resistant cells in NSCLC through activating p53 pathway. Front. Oncol. 9 306

Article  Google Scholar 

Wang H, Zou L, Ma K, Yu J, Wu H, Wei M and Xiao Q 2017a Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer. Mol Cancer 16 152

Article  Google Scholar 

Wang R, Deng X, Yoshioka Y, et al. 2017b Effects of SMYD2-mediated EML4-ALK methylation on the signaling pathway and growth in non-small-cell lung cancer cells. Cancer Sci. 108 1203–1209

CAS  Article  Google Scholar 

Wang T, Wu H, Liu S, et al. 2018 SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance. Cancer Lett. 430 11–24

CAS  Article  Google Scholar 

Wang Y, Xie BH, Lin WH, et al. 2019 Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2. Oncogene 38 4948–4961

CAS  Article  Google Scholar 

Wang G, Huang Y, Yang F, et al. 2020 High expression of SMYD3 indicates poor survival outcome and promotes tumour progression through an IGF-1R/AKT/E2F-1 positive feedback loop in bladder cancer. Aging 12 2030–2048

CAS  Article  Google Scholar 

Wu H, Wang H, Guan S, et al. 2017 Cell-specific regulation of proliferation by Ano1/TMEM16A in breast cancer with different ER, PR, and HER2 status. Oncotarget 8 84996–85013

Article  Google Scholar 

Wu X, Xu Q, Chen P, et al. 2019 Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer. Cancer Manag. Res. 11 8125–8133

CAS  Article  Google Scholar 

Yan Y, Ding X, Han C, et al. 2022 Involvement of TMEM16A/ANO1 upregulation in the oncogenesis of colorectal cancer. Biochim. Biophys. Acta Mol. Basis Dis. 1868 166370

CAS  Article  Google Scholar 

Yu L, Yang G, Weng X, et al. 2015 Histone methyltransferase SET1 mediates angiotensin II-induced endothelin-1 transcription and cardiac hypertrophy in mice. Arterioscler. Thromb. Vasc. Biol. 35 1207–1217

CAS  Article  Google Scholar 

Zeng X, Pan D, Wu H, et al. 2019 Transcriptional activation of ANO1 promotes gastric cancer progression. Biochem. Biophys. Res. Commun. 512 131–136

CAS  Article  Google Scholar 

Zhang K, Wang J, Yang L, et al. 2018 Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1alpha and APC2 gene expression in non-small cell lung cancer. Mol. Cancer 17 153

CAS  Article  Google Scholar 

Zhang ZY, Gao XH, Ma MY, et al. 2020 CircRNA_101237 promotes NSCLC progression via the miRNA-490–3p/MAPK1 axis. Sci. Rep. 10 9024

CAS  Article  Google Scholar 

Zhou Z, Jiang H, Tu K, et al. 2019 ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res. 38 18

Article  Google Scholar 

Zhu CL and Huang Q 2020 Overexpression of the SMYD3 promotes proliferation, migration, and invasion of pancreatic cancer. Dig. Dis. Sci. 65 489–499

CAS  Article  Google Scholar